Going in reverse is faster way forward for Crescent Bio’s cancer immunotherapy

The latest stories trending on MedCity News.

Editor's Pick

Top Story Going In Reverse Is Faster Way Forward for Crescent Bio's Cancer Immunotherapy Crescent Biopharma is going public via a reverse merger with GlycoMimetics that will capitalize the combined company with $200 million. Crescent's lead program is a bispecific antibody for cancer that replicates the properties of a Summit Therapeutics bispecific drug that recently trounced Merck's blockbuster med Keytruda in a pivotal head-to-head study. Sponsored It's All About the Connection Presented by LiveWorld 🚨 Creative Warning 🚨 The content you'll see may be too captivating for traditional agency standards. Our bold creative contains dangerously engaging visuals that may cause sudden inspiration and uncontrollable industry envy. Viewer discretion is advised: you may find it impossible to return to your current agency after talking to us.  Learn More. Announcing INVEST 2025 in Chicago Join us on April 29-30, 2025, for INVEST 2025, MedCity's flagship event uniting industry leaders, innovators, and investors right in the heart of Chicago. Our agenda has been finalized and you can expect engaging sessions on AI in healthcare, PBM innovations, and post-pandemic strategies. Whether you're an investor, entrepreneur, or expert in your field, INVEST 2025 offers an invaluable opportunity to connect, learn, and elevate your impact. Location: 333 North Green, Chicago, IL Dates: April 29-30, 2025 Register Today for Best Rate

Featured News

Black, Latino, Women Healthcare Leaders Sign Letters in Support of Kamala Harris More than two dozen Black and Latino health tech leaders have endorsed Kamala Harris for president. Another group of over 500 women healthcare leaders has also come out in support of Harris. 'You Almost Have to Be Doing It': Why Scott Gottlieb Thinks All Doctors Will Use LLMs Soon Large language models will soon become a much bigger part of doctors' clinical workflows, former FDA Commissioner Scott Gottlieb said Tuesday at the 3rd Annual Summit on the Future of Rural Health Care. MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes In this episode, we're joined by Dr. Tiffany Inglis, national medical director for women and children's health at Carelon Health, a subsidiary of Elevance Health. Inglis discusses a paper Elevance Health Public Policy Institute recently published about doulas. Are You a Startup Looking for an Audience of Investors? We Have The Perfect Pitch Contest for You! As companies begin to make plans for 2025, add the INVEST Pitch Perfect Contest to your calendar. VBC, MA, FHIR and Modern Care We know from everyday purchasing of goods and services that you have to combine what you're getting with what you're paying for that good or service. But how does this basic consumer supplier concept play out in US healthcare? A CEO's Guide to AI Exploration: Transforming Organizations and Mindsets Try a variety of LLM-based tools yourself. Understand the risks, limitations, and who is working on putting quality frameworks and guardrails in place. Engage your employees and partners in discussions about what might now be possible.

Resources

AI in Healthcare: The Next Chapter The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. Request Your Free eBook Now

MedCity News • PO Box 901 • New York, NY unsubscribe